# |
PMID |
Sentence |
1 |
1289237
|
The hypoglycemic effect of Bordetella pertussis (Challenge strain No.18323) purified cell extract (protein with traces of carbohydrates, 2 mg%) administered (0.1 mg/100 g body wt. i.v.) into mice on the activities of the key regulatory enzymes, viz. glucokinase, phosphofructokinase, pyruvate kinase, glyceraldehyde phosphodehydrogenase, glucose-6-phosphate dehydrogenase (G-6-PD) and lactate dehydrogenase, of glycolytic pathway in liver has been studied at varying intervals after injection.
|
2 |
7004008
|
This study revealed the strengthening of synchronous conjugations between neutrophils and lymphocytes on the level of glucose-6-phosphate dehydrogenase and NAD-dependent malate dehydrogenase activity, as well as the appearance of diachronic correlations, both intra- and intercellular, between these 2 enzymes.
|
3 |
7569773
|
Changes in biological activities could be followed by employing enzymes (glucose-6-phosphate dehydrogenase and human placental alkaline phosphatase) as antigens.
|
4 |
23212119
|
The activity of glucose-6-phosphate dehydrogenase, hexokinase, and glutaminase was measured.
|
5 |
23212119
|
There was a significant increase in IL-2 production and decrease in IL-4 in the trained group compared with sedentary controls.
|
6 |
23212119
|
IL-2R and TNFR increased in trained rats while IL-4R decreased and were more pronounced in T lymphocytes compared with B lymphocytes.
|
7 |
23212119
|
In both lymphocyte subsets, exercise training significantly increased the expression of CD54+ and CD30+ cell markers.
|
8 |
24012107
|
Metabolic fluxes calculated by metabolite balance analysis showed differences mainly in reactions catalyzed by pyruvate kinase and glucose 6-phosphate dehydrogenase.
|
9 |
25981166
|
In addition, the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase were also significantly inhibited by all mercurials, with inhibition intensity of Hg(2+)>MeHg≈EtHg>TM (p<0.05).
|
10 |
26242747
|
Meeting sessions included: an update on the Greater Mekong Subregion elimination strategy; an update on the RTS,S vaccine; G6PD testing to support the safe use of anti-relapse therapy for Plasmodium vivax; update from the Vector Control Advisory Group; newly proposed evidence reviews or consultations on malaria terminology, malaria in pregnancy, and the feasibility of eradication; as well as updates from the World Health Organization Global Malaria Programme regarding their strategy update and policy setting processes.
|